News
On Wednesday, Novavax Inc. (NASDAQ:NVAX) reported second-quarter 2025 sales of $239.24 million, compared to $415 million a year ago, beating the consensus of $156.29 million. The company completed the ...
Investor's Business Daily on MSN15m
Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
Avidity BiosciencesRNA stock rocketed Wednesday on a report NovartisNVS made an attempt to buy the rare disease-focused ...
From geopolitics to climate, tech to social change, News18 World live blog delivers real-time updates on what is the latest ...
Stock markets edged higher Wednesday as traders assessed the latest corporate earnings and awaited President Donald Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback